title: Lipid lowering therapy for adults with diabetes.
abstract: The number of adults in Australia with diabetes has trebled over the past 2 decades. Diabetes confers an increased risk of cardiovascular disease (CVD) and CVD is the leading cause of morbidity and mortality in patients with diabetes. Hyperlipidaemia occurs commonly in people with diabetes and is an independent CVD risk factor.
authors.affiliation: Sansom Institute, University of South Australia. leslie.jackowski@unisa.edu.au
authors.forename: Leslie
authors.initials: L
authors.lastname: Jackowski
authors.forename: Josephine
authors.initials: J
authors.lastname: Crockett
authors.forename: Debra
authors.initials: D
authors.lastname: Rowett
mesh_terms: D000328:Adult; D001315:Australia / Q000453:epidemiology; D002318:Cardiovascular Diseases / Q000209:etiology; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006943:Hyperglycemia / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008019:Life Style; D017410:Practice Guidelines as Topic
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents